Incentivizing antibiotic access and innovation

A policy brief developed in collaboration with Global R&D AMR Hub with the result of in-depth interviews with 13 countries pointing to a clear need for specific and detailed incentives.

Also available in: French | German | Spanish

Country visits to discuss implementation of incentives

Report on the meetings with the first-mover volunteer countries, Member State forums and other participating countries to design more granular incentives in line with country expectations.

Financing pull mechanisms for antibiotic-related innovation: Opportunities for Europe

An article published by Oxford University Press that takes a closer look at four potential financing models (diagnosis-related group carve-out, stewardship taxes, transferable exclusivity voucher, and a European-based “pay or play” model) and evaluate them from a European perspective.

A strategy for implementing multi-country incentives in Europe to stimulate antimicrobial innovation and access

A concrete strategy for the implementation of multi-country incentives in a EU context to stimulate antimicrobial and diagnostic innovation and access. This strategy is aligned with ongoing non-European efforts.